AU Stock MarketDetailed Quotes
NOX Noxopharm Ltd
- 0.130
- -0.005-3.70%
20min DelayNot Open Nov 4 16:00 AET
37.99MMarket Cap-10833P/E (Static)
0.130High0.130Low350.79KVolume0.130Open0.135Pre Close45.60KTurnover0.15052wk High0.18%Turnover Ratio292.24MShares0.05152wk Low-0.012EPS TTM24.77MFloat Cap1.590Historical HighLossP/E (Static)190.51MShs Float0.033Historical Low-0.012EPS LYR0.00%Amplitude--Dividend TTM6.84P/B1Lot Size--Div YieldTTM
About Noxopharm Ltd Company
Noxopharm Ltd is an Australian clinical-stage drug development company focused on discovering and developing novel treatments for cancer and inflammation, as well as improving mRNA vaccines, based on two preclinical platforms. It is engaged in one segment which is the clinical development in the field of both oncology and non-oncology in the pan-pacific region.
Company Profile
SymbolNOX
Company NameNoxopharm Ltd
Founded2015
MarketASX
Fiscal Year Ends06-30
Address60 Linksley Ave
CityGlenhaven
CountryAustralia
Zip Code2156
Websitehttps://www.noxopharm.com
Share RegistryAUTOMIC REGISTRY SERVICES
Level 1, 45 Clarence Street, SYDNEY, NSW, AUSTRALIA, 2000
13 25 83
Company Executives
- Name
- Position
- Salary
- Gisela Mautner
- Chief Executive Officer,Managing Director
- --
- Peter Ashley Marks
- Non-Executive Director,Non-Executive Deputy Chairman
- --
- Frederick (Fred) Bart
- Non-Executive Director,Non-Executive Chairman
- --
- Boris Patkin
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data